Reducing the Burden of Stage B Heart Failure and the Global Pandemic of Cardiovascular Disease: Time to Go to War with the “Barefoot” Troops!  Ragavendra.

Slides:



Advertisements
Similar presentations
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College.
Advertisements

Atrial Fibrillation and Heart Failure Andrew A. Grace, MB, PhD, FRCP Heart Failure Clinics Volume 9, Issue 4, (October 2013) DOI: /j.hfc
Stage B, a Pre-cursor of Heart Failure Jay N. Cohn, MD, Gary S. Francis, MD Heart Failure Clinics Volume 8, Issue 1, Pages xvii-xviii (January 2012) DOI:
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for percutaneous coronary intervention.
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.
Colloquium on Therapy of Right Heart Failure
Hypertension guidelines What’s all the controversy about 2015
Volume 56, Issue 1, Pages (July 1969)
Major recommendation for statin therapy for ASCVD prevention
Epidemiology and Treatment of Lung Cancer in Seattle
Robert C. Stanton, MD  American Journal of Kidney Diseases 
American College of Cardiology Foundation/American Heart Association 2009 heart failure staging guidelines. CHF, congestive heart failure; CM, cardiomyopathy;
Guidelines for perioperative cardiac evaluation from the American College of Cardiology/American Heart Association task force are effective for stratifying.
Reproduced with permission from Yancy, C. W. et al. 2017
Never Too Late to Drink From the Fountain of Youth
Preface Heart Failure Clinics
Ragavendra R. Baliga, MD, MBA  Heart Failure Clinics 
Volume 153, Issue 4, Pages (April 2018)
Irbedrin Group Training
Ragavendra R. Baliga, MD, MBA  Heart Failure Clinics 
Martin W. Schoen, MD, MPH, Joanne Salas, MPH, Jeffrey F
Ragavendra R. Baliga, MD, MBA  Heart Failure Clinics 
Editorial: Depression in Heart Failure is Double Trouble: Warding off the Blues Requires Early Screening  Ragavendra R. Baliga, MD, MBA  Heart Failure.
Preface Heart Failure Clinics Volume 5, Issue 3, (July 2009)
The Challenge of Managing Drugs Safely in the Newborn
Volume 2, Issue 3, Pages xi-xiii (July 2006)
CardioRenal Disease Cardiology Clinics
Volume 6, Issue 3, Pages xvii-xviii (July 2010)
Editorial Heart Failure Clinics
Reducing the Burden of Stage B Heart Failure and the Global Pandemic of Cardiovascular Disease: Time to Go to War with the “Barefoot” Troops!  Ragavendra.
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
Epidemiology of hypertension in India: Insights from PURE
Epidemiology of hypertension in India: Insights from PURE
Editorial Heart Failure Clinics
Heart Failure: A Global Pandemic and Not Just a Disease of the West
Editorial Heart Failure Clinics
A Journey into the Science of Cardiovascular Chronobiology
β-Blockers in Heart Failure: Breaking Tradition to Avoid Diabetes?
Volume 10, Issue 4, Pages ix-x (October 2014)
Stage B, a Pre-cursor of Heart Failure
Coronary Artery Disease in Women: Shyly Bold?
Early Detection and Monitoring of Vulnerable Myocardium in Patients Receiving Chemotherapy: Is It Time to Change Tracks?  Ragavendra R. Baliga, MD, MBA 
Volume 7, Issue 2, Pages xix-xx (April 2011)
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Clinical Trials to “Real-World” Heart Failure: Applying Risk Stratification to Deliver Personalized Care  Ragavendra R. Baliga, MD, MBA  Heart Failure.
Dorothea Nitsch, MD, MSc  American Journal of Kidney Diseases 
Volume 11, Issue 1, Pages xv-xvii (January 2015)
Christopher M. O’Connor, MD  Heart Failure Clinics 
Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S
Editorial Heart Failure Clinics
Pulmonary Hypertension
Augusto Miyashiro, M.D., Soul J. Grosberg, M.D., Simon Wapnick, M.D. 
Preface Heart Failure Clinics
Volume 25, Issue 4, Pages xi-xiii (November 2007)
Biomarkers of Heart Failure: Past, Present, and Future
Atrial Fibrillation and Heart Failure: It Takes Two to Tango
Guidelines should bother us, not comfort us
Editorial Heart Failure Clinics
Calcification of the Coronary Artery
Preface Clinics in Liver Disease
A World View of Heart Failure Requiring Hospitalization
Heart Failure with Preserved Ejection Fraction: A Bouillabaisse
Volume 133, Issue 4, Pages (April 2008)
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management  Anne M. Gillis, MD, FRCPC, Atul Verma, MD, FRCPC, Mario.
Volume 6, Issue 3, Pages xvii-xviii (July 2010)
Figure 5 Algorithm for the management of hypertension
Statins or Status Quo? Heart Failure Clinics
J. David Spence, BA, MBA, MD  Canadian Journal of Cardiology 
β-Blocker Use for the Stages of Heart Failure
Presentation transcript:

Reducing the Burden of Stage B Heart Failure and the Global Pandemic of Cardiovascular Disease: Time to Go to War with the “Barefoot” Troops!  Ragavendra R. Baliga, MD, MBA  Heart Failure Clinics  Volume 8, Issue 2, Pages ix-xiii (April 2012) DOI: 10.1016/j.hfc.2012.02.001 Copyright © 2012 Elsevier Inc. Terms and Conditions

Fig. 1 Stage A and stage heart failure: overview. (Adapted from Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112(12):e154–235; with permission.) Heart Failure Clinics 2012 8, ix-xiiiDOI: (10.1016/j.hfc.2012.02.001) Copyright © 2012 Elsevier Inc. Terms and Conditions

Fig. 2 Pyramid of HF in population. (From Young JB, Narula J. Prevention should take center stage. Cardiol Clin 2007;25(4):xi–xiii; with permission.) Heart Failure Clinics 2012 8, ix-xiiiDOI: (10.1016/j.hfc.2012.02.001) Copyright © 2012 Elsevier Inc. Terms and Conditions

Fig. 3 Change over time in mean BMI, systolic blood pressure, and total cholesterol by countries’ income category: BMI is increasing in all three economic categories. In high-income countries, blood pressure and total cholesterol are decreasing. In middle-income countries, there is no major change in blood pressure and total cholesterol is decreasing. In low-income countries, blood pressure is increasing and total cholesterol is decreasing.13 (From Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet 2011;377(9765):530. [www.thelancet.com]; with permission.) Heart Failure Clinics 2012 8, ix-xiiiDOI: (10.1016/j.hfc.2012.02.001) Copyright © 2012 Elsevier Inc. Terms and Conditions

Fig. 4 Number of drugs taken by patients with coronary artery disease by country economic status. The drugs counted were aspirin, β-blockers, ACE inhibitors or ARBs, or statins. (From Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011;378(9798):1231–43; with permission.) Heart Failure Clinics 2012 8, ix-xiiiDOI: (10.1016/j.hfc.2012.02.001) Copyright © 2012 Elsevier Inc. Terms and Conditions

Ragavendra R. Baliga, MD, MBA, Consulting Editor Heart Failure Clinics 2012 8, ix-xiiiDOI: (10.1016/j.hfc.2012.02.001) Copyright © 2012 Elsevier Inc. Terms and Conditions

James B. Young, MD, Consulting Editor Heart Failure Clinics 2012 8, ix-xiiiDOI: (10.1016/j.hfc.2012.02.001) Copyright © 2012 Elsevier Inc. Terms and Conditions